Compare ARK Genomic Revolution ETF (ARKG) vs LYFT Inc (LYFT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs LYFT Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while LYFT Inc trades at $15.61 (market cap $5.93B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, LYFT Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | LYFT | |
|---|---|---|
Sector | Sector/Thematic | Industrials |
52-Week High | $43.57 | $24.57 |
52-Week Low | $23.09 | $12.65 |
Market Cap | — | $5.93B |
Enterprise Value | — | $5.46B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Lyft trades at $15.61, down 0.83% on the day, with a bullish technical signal from moving averages and key indicators like ADX. The company shows strong profitability with a net income margin of 43.82% and robust cash flow of $891M in 2025. Recent news highlights expansion into Europe and autonomous vehicle partnerships, while analyst consensus is mixed with a $18.25 price target.
Lyft presents an attractive valuation with a P/E of 2.28 and P/S of 0.99, but faces risks from competitive pressures and inconsistent earnings beats. The stock's upside potential hinges on execution of growth initiatives, though regulatory concerns and market volatility remain key watchpoints for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About LYFT Inc
Lyft is the second-largest ride-sharing service provider in the U.S., connecting riders and drivers over the Lyft app. Lyft recently entered the Canadian market in an effort to expand its market outside the U.S. Incorporated in 2013, Lyft offers a variety of rides via private vehicles, including traditional private rides, shared rides, and luxury ones. Besides ride-share, Lyft also has entered the bike- and scooter-share market to bring multimodal transportation options to users.
Read more on LYFT →
